Literature DB >> 4399190

Use of bundle of His potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents.

C S Smithen, R Balcon, E Sowton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4399190      PMCID： PMC458455          DOI： 10.1136/hrt.33.6.955

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  8 in total

1.  Electrical activity during the P-R interval.

Authors:  B F HOFFMAN; P F CRANEFIELD; J H STUCKEY; A A BAGDONAS
Journal:  Circ Res       Date:  1960-11       Impact factor: 17.367

2.  The electrical activity of the bundle of His.

Authors:  J ALANIS; H GONZALEZ; E LOPEZ
Journal:  J Physiol       Date:  1958-06-18       Impact factor: 5.182

Review 3.  Clinical value of the electrogram of the conduction system.

Authors:  A N Damato; S H Lau
Journal:  Prog Cardiovasc Dis       Date:  1970-09       Impact factor: 8.194

4.  Analysis of the A-V conduction defect in complete heart block utilizing His bundle electrograms.

Authors:  O S Narula; B J Scherlag; R P Javier; F J Hildner; P Samet
Journal:  Circulation       Date:  1970-03       Impact factor: 29.690

5.  Localization of A-V conduction defects in man by recording of the His bundle electrogram.

Authors:  O S Narula; L S Cohen; P Samet; J W Lister; B Scherlag; F J Hildner
Journal:  Am J Cardiol       Date:  1970-02       Impact factor: 2.778

6.  Catheter technique for recording His bundle activity in man.

Authors:  B J Scherlag; S H Lau; R H Helfant; W D Berkowitz; E Stein; A N Damato
Journal:  Circulation       Date:  1969-01       Impact factor: 29.690

7.  Study of atrioventricular conduction in man using electrode catheter recordings of His bundle activity.

Authors:  A N Damato; S H Lau; R H Helfant; E Stein; W D Berkowitz; S I Cohen
Journal:  Circulation       Date:  1969-03       Impact factor: 29.690

8.  Comparison of haemodynamic effects of oxprenolol (trasicor), alprenolol (aptin), and sotalol (MJ 1999) in man.

Authors:  D G Gibson; J Hoy; E Sowton
Journal:  Br Heart J       Date:  1970-07
  8 in total
  13 in total

1.  [Clinical value of His bundle electrography (author's transl)].

Authors:  L Seipel; A Both; F Loogen
Journal:  Klin Wochenschr       Date:  1975-06-01

2.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

3.  Electrophysiological effects of acebutolol.

Authors:  J W Mason; R A Winkle; P J Meffin; D C Harrison
Journal:  Br Heart J       Date:  1978-01

4.  Tachyarrhythmia in severe imipramine overdose controlled by practolol.

Authors:  K G Brown; H U McMichen; D S Briggs
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

5.  Effects of new beta-blocking agent (DL-tiprenolol) on conduction within normal and anomalous atrioventricular pathways in Wolff-Parkinson-White syndrome.

Authors:  J Roelandt; L Schamroth; P G Hugenholtz
Journal:  Br Heart J       Date:  1972-12

6.  Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.

Authors:  R A Spurrell; D M Krikler; E Sowton
Journal:  Br Heart J       Date:  1974-03

7.  Atrioventricular conduction in patients with short PR intervals and normal QRS complexes.

Authors:  J K Bissett; A J Thompson; N DeSoyza; M L Murphy
Journal:  Br Heart J       Date:  1973-02

Review 8.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

9.  The effect of a new antiarrhythmic agent, flecainide acetate, on systolic time intervals.

Authors:  K A Muhiddin; E Shaw; A Blackett; L Patel; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent.

Authors:  C Robinson; J Birkhead; B Crook; K Jennings; D Jewitt
Journal:  Br Heart J       Date:  1978-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.